Mercer Global Advisors Inc Moderna, Inc. Transaction History

Mercer Global Advisors Inc

$39.5 Billion
Q2 2024

A detailed history of Mercer Global Advisors Inc transactions in Moderna, Inc. stock. As of the latest transaction made, Mercer Global Advisors Inc holds 23,078 shares of MRNA stock, worth $1.16 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

23,078

Previous 25,093 8.03%

Holding current value

$1.16 Million

Previous $2.67 Million 2.47%

% of portfolio

0.01%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$101.21 - $166.61 $203,938 - $335,719	-2,015 Reduced 8.03%	23,078 $2.74 Million
Q1 2024 May 15, 2024	SELL	$85.37 - $115.44 $957,936 - $1.3 Million	-11,221 Reduced 30.9%	25,093 $2.67 Million
Q4 2023 Feb 14, 2024	SELL	$69.51 - $104.43 $103,917 - $156,122	-1,495 Reduced 3.95%	36,314 $3.61 Million
Q3 2023 Nov 13, 2023	SELL	$96.41 - $126.61 $2.99 Million - $3.93 Million	-31,053 Reduced 45.09%	37,809 $3.91 Million
Q2 2023 Aug 14, 2023	BUY	$118.5 - $160.53 $149,547 - $202,588	1,262 Added 1.87%	68,862 $8.37 Million
Q1 2023 May 15, 2023	BUY	$135.66 - $197.02 $399,518 - $580,223	2,945 Added 4.55%	67,600 $10.4 Million
Q4 2022 Feb 08, 2023	BUY	$118.38 - $210.04 $1.39 Million - $2.47 Million	11,773 Added 22.26%	64,655 $11.6 Million
Q3 2022 Nov 15, 2022	BUY	$118.07 - $194.18 $2.39 Million - $3.94 Million	20,278 Added 62.19%	52,882 $6.25 Million
Q2 2022 Aug 10, 2022	BUY	$117.13 - $176.59 $423,776 - $638,902	3,618 Added 12.48%	32,604 $4.66 Million
Q1 2022 May 10, 2022	BUY	$126.46 - $235.05 $1.51 Million - $2.8 Million	11,905 Added 69.7%	28,986 $4.99 Million
Q4 2021 Feb 04, 2022	BUY	$225.82 - $368.51 $271,887 - $443,686	1,204 Added 7.58%	17,081 $4.34 Million
Q3 2021 Nov 10, 2021	BUY	$221.9 - $484.47 $2.07 Million - $4.52 Million	9,337 Added 142.77%	15,877 $6.11 Million
Q2 2021 Aug 10, 2021	BUY	$129.91 - $234.98 $163,296 - $295,369	1,257 Added 23.79%	6,540 $1.54 Million
Q1 2021 May 11, 2021	SELL	$109.18 - $185.98 $39,195 - $66,766	-359 Reduced 6.36%	5,283 $692,000
Q4 2020 Feb 12, 2021	SELL	$65.74 - $169.86 $88,617 - $228,971	-1,348 Reduced 19.28%	5,642 $589,000
Q3 2020 Dec 10, 2020	BUY	$54.34 - $94.85 $143,620 - $250,688	2,643 Added 60.8%	6,990 $495,000
Q2 2020 Aug 10, 2020	BUY	$29.67 - $80.0 $128,975 - $347,760	4,347 New	4,347 $279,000

Others Institutions Holding MRNA

# of Institutions

1,022

Shares Held

242M

Call Options Held

9.07M

Put Options Held

13.1M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $19.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mercer Global Advisors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Mercer Global Advisors Inc with notifications on news.

Account

Mercer Global Advisors Inc Moderna, Inc. Transaction History